Intended for healthcare professionals


US public health chief resigns over tobacco investments

BMJ 2018; 360 doi: (Published 02 February 2018) Cite this as: BMJ 2018;360:k556
  1. Owen Dyer

Brenda Fitzgerald, President Trump’s appointment to lead the US Centers for Disease Control and Prevention (CDC), has resigned after just six months in the role, after revelations of a tobacco stock purchase early in her tenure.

Many observers said that news of the tobacco investment, revealed by the Politico news website, was the last straw for an administrator who had already officially recused herself from much of a CDC director’s normal role because of financial conflicts of interest.

An ethics agreement Fitzgerald signed soon after taking up the post last July noted that, for contractual reasons, she could …

View Full Text

Log in

Log in through your institution


* For online subscription